http://www.raredr.com/casestudies/polycythemia-vera/treating-pcv
Treating Polycythemia Vera Patients Refractory to Hydroxyurea

Srdan Verstovsek, MD, PhD




In a case study of a  45-year old man with polycythemia vera is refractory to hydroxyurea, Srdan Verstovsek, MD, PhD of the MD Anderson Cancer Center in Houston, Texas describes how ruxolitinib is a viable treatment option.
Printer Printing...
$content$